Urolithin A Capsules Supplier & Exporters for Dublin

Urolithin A (3,8-dihydroxy-6H-benzo[c]chromen-6-one) has transitioned from an experimental metabolite to one of the most commercially vital cellular longevity compounds in modern nutraceutical science. Naturally generated via the postbiotic transformation of ellagitannins and ellagic acid by distinct human gut microflora (primarily Gordonibacter pamelaeae and Gordonibacter urolithinfaciens), Urolithin A directly triggers mitophagy—the selective autophagic clearance of damaged, dysfunctional mitochondria. However, empirical clinical diagnostics reveal that less than 30% of the European population possesses the specific gut microbiome composition required to synthesize bioactive levels of Urolithin A through dietary intake alone (such as pomegranates, walnuts, and specific berries). This biological shortfall has created an exponential commercial demand across County Dublin and the broader Irish market for direct, bioavailable oral supplementation.

As a seasoned contract manufacturer operating under strict NSF 455-2 GMP and ISO 22000 mandates since 2006, Shaanxi ESNO Biotech Co., Ltd. delivers pharmaceutical-purity Urolithin A synthetic and naturally derived extracts. Our extraction, synthesis, and crystallization facilities yield standard purity tiers exceeding 98% (verified via Ultra-High Performance Liquid Chromatography, UHPLC). Encapsulated in acid-resistant, certified non-GMO vegetarian HPMC (hydroxypropyl methylcellulose) shells, our finished capsules bypass early gastric degradation, delivering targeted intestinal dissolution for optimized systemic absorption and maximum cellular uptake across muscle tissues and neural pathways.

The Irish dietary supplements market is experiencing structural reconfiguration, moving away from generic multivitamins toward targeted longevity therapeutics. Driven by high disposable income in urban Dublin hubs, an educated professional workforce, and pervasive consumer health literacy, cellular longevity compounds (including Urolithin A, NAD+ precursors, Spermidine, and specialized Shilajit CoQ10 complexes) are capturing market share at an annual compound rate exceeding 16.4%. Irish consumers have grown cautious regarding ingredient origins, demanding verifiable third-party heavy metal testing, clear batch certification, and zero synthetic flow agents such as magnesium stearate or titanium dioxide.

Furthermore, regulatory enforcement by the FSAI and the Health Products Regulatory Authority (HPRA) emphasizes stringent label accuracy. Importers and local brand creators must ensure that health claims adhere precisely to EU Regulation (EC) No 1924/2006. Brand differentiation in Dublin retailers now relies heavily on partnering with certified raw manufacturers capable of providing end-to-end documentation packs—including stability testing data, Certificate of Analysis (COA) for every manufacturing lot, non-GMO declarations, and TSE/BSE safety statements.